Enhancement of fibrinolysis by a factor XA inhibitor edoxaban and combination with an inhibitor of activated thrombin-activatable fibrinolysis inhibitor in vitro

被引：0
|
作者：
Morishima, Y. [1 ]
Kamisato, C. [1 ]
Furugohri, T. [1 ]
机构：
[1] Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo, Japan
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO353-MON
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [41] Deficiency of Thrombin-activatable Fibrinolysis Inhibitor Worsens Bronchial Asthma
    Takagi, T.
    Urawa, M.
    Naitou, M.
    Fujiwara, A.
    Ebihara, A.
    Kobayashi, T.
    Kobayashi, H.
    D'Alessandro-Gabazza, C. N.
    Gabazza, E. C.
    Taguchi, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [42] Association of Thrombin-Activatable Fibrinolysis Inhibitor with Acute Pulmonary Embolism
    Yildiz, Abdulkerim
    Katar, Didem
    Soydas, Ayse Ozden
    Albayrak, Murat
    HAMOSTASEOLOGIE, 2022, 42 (03): : 180 - 184
  • [43] Thrombin-activatable fibrinolysis inhibitor in kidney transplant recipient with dyslipidemia
    Malyszko, J
    Malyszko, JS
    Hryszko, T
    Mysliwiec, M
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (06) : 2219 - 2221
  • [44] Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) phenotype in severe sepsis
    Francisco, E
    Ruiz-Rodríguez, JC
    Caballero, J
    Monasterio, J
    Bóveda, JL
    INTENSIVE CARE MEDICINE, 2002, 28 : S17 - S17
  • [45] Role of Thrombin-Activatable Fibrinolysis Inhibitor in Allergic Bronchial Asthma
    Atsushi Fujiwara
    Osamu Taguchi
    Takehiro Takagi
    Corina N. D’Alessandro-Gabazza
    Daniel Boveda-Ruiz
    Masaaki Toda
    Atsushi Yasukawa
    Yuki Matsushima
    Yasushi Miyake
    Hiroyasu Kobayashi
    Tetsu Kobayashi
    Paloma Gil-Bernabe
    Masahiro Naito
    Masamichi Yoshida
    John Morser
    Yoshiyuki Takei
    Esteban C. Gabazza
    Lung, 2012, 190 : 189 - 198
  • [46] Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss
    Masini, Silvia
    Ticconi, Carlo
    Gravina, Paolo
    Tomassini, Monica
    Pietropolli, Adalgisa
    Forte, Vittorio
    Federici, Giorgio
    Piccione, Emilio
    Bernardini, Sergio
    FERTILITY AND STERILITY, 2009, 92 (02) : 694 - 702
  • [47] Structure-function relationships in thrombin-activatable fibrinolysis inhibitor
    Plug, T.
    Meijers, J. C. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (04) : 633 - 644
  • [48] Thrombin-activatable fibrinolysis inhibitor activity in healthy and diseased dogs
    Jessen, Lisbeth R.
    Wiinberg, Bo
    Kjelgaard-Hansen, Mads
    Jensen, Asger L.
    Rozanski, Elizabeth
    Kristensen, Annemarie T.
    VETERINARY CLINICAL PATHOLOGY, 2010, 39 (03) : 296 - 301
  • [49] Fibrinolysis and diabetic vascular disease: roles of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor
    Aso, Yoshimasa
    FUTURE LIPIDOLOGY, 2006, 1 (04): : 429 - 440
  • [50] A Direct Oral Anticoagulant Edoxaban Enhanced Fibrinolysis Via Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor Activation and Enhancement of Plasmin Generation in Human Plasma
    Morishima, Yoshiyuki
    Honda, Yuko
    Furugohri, Taketoshi
    BLOOD, 2018, 132
12345